Frontlight ResearchEarly access
Trial site
Tampa General Hospital-Cancer Institute
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Diffuse large B-cell lymphoma2 trials
- Acute myeloid leukaemia1 trial
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Follicular lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Lupus (SLE)1 trial
- Mantle cell lymphoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Ovarian cancer1 trial
- and 1 more
- Phase
- Phase 12 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 31 trial
- Status
- Recruiting2 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- BeOne Medicines1 trial
- GE Healthcare1 trial
- Incyte Corporation1 trial
- Kite, A Gilead Company1 trial
- Pfizer1 trial
- and 2 more
Running trials
Recruiting
Enrolling by invitation
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Lupus (SLE)1 recruiting
- Mantle cell lymphoma1 recruiting
- Ovarian cancer1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026